Dr Reddy's launches drug for neck, head cancer

Dr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This drug is for treating recurrent or metastatic nasopharyngeal carcinoma. It will be marketed under the name Zytorvi. Before this, the standard treatment was chemotherapy with gemcitabine and cisplatin.